Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-164368
Filing Date
2017-05-09
Accepted
2017-05-09 17:13:49
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d367886d10q.htm 10-Q 316836
2 EX-31.1 d367886dex311.htm EX-31.1 6624
3 EX-31.2 d367886dex312.htm EX-31.2 6724
4 EX-32.1 d367886dex321.htm EX-32.1 4491
  Complete submission text file 0001193125-17-164368.txt   2949590

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zsan-20170331.xml EX-101.INS 558752
6 XBRL TAXONOMY EXTENSION SCHEMA zsan-20170331.xsd EX-101.SCH 38219
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zsan-20170331_cal.xml EX-101.CAL 54189
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zsan-20170331_def.xml EX-101.DEF 117613
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20170331_lab.xml EX-101.LAB 330825
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20170331_pre.xml EX-101.PRE 225256
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

EIN.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 17827477
SIC: 2834 Pharmaceutical Preparations